Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-22

Clinical Trial Update: Assessing the Efficacy of Repeat, Monthly Treatments of Deoxycholate for NF1 Associated Cutaneous Neurofibromas (cNFs) [Phase 1]

View source ↗

Summary

A Phase 1 study at Massachusetts General Hospital is evaluating repeat monthly injections of sodium deoxycholate for cutaneous neurofibromas in neurofibromatosi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sodium deoxycholate (sodium deoxycholate)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Neurofibromas, Cutaneous, Neurofibromatosis 1 | Phase 1 | Status: ENROLLING_BY_INVITATION